The table below shows Connect Biopharma Holdings Ltd's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$169.00K
$16.00K
$48.00K
$0.00
$1.22M
$24.12M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$15.03M
$11.11M
$8.77M
$6.63M
$9.01M
$5.35M
SG&A
CNTB annual revenue (10-K history)
Connect Biopharma Holdings Ltd reported annual revenue of $64.00K for fiscal year 2025. That is down 99.8% from $26.03M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.